Nike: BMO Lowers Price Target To $170 Following Q1 Results

Earlier this week, Nike Inc (NYSE: NIKE) reported its fiscal first quarter of 2022. The company reported revenues of $12.2 billion, up 16% year over year. NIKE Direct sales came in at $4.7 billion for the quarter, up 28% while their digital brand sales increased 29%. The company reported gross margins of 46.5% higher than the 44.8% last year. The company had a 17.3% operating margin while net income was $1.87 billion, or earnings per share of $1.16.

A number of analysts changed their 12-month price target off the back of the results. This brought the average 12-month price target down from $184.37 to $181.13, or a 24% upside. There are currently 34 analysts covering the stock, with 10 having strong buy ratings, 19 having buys, 4 have holds and 1 analyst has a strong sell on Nike. The street high sits at $213 from Stifel, while the lowest comes in at $134.

BMO Capital Markets sent out an analyst note shortly after the company reported earnings, reiterating their outperform rating but lowering their 12-month price target to $170, down from $174, saying that there is a compelling long-term competitive advantage Nike has gained but the macro headwinds shouldn’t be ignored.

For the quarter, the company beat slightly on many of BMO’s estimates, with BMO forecasting $11.979 billion in revenue with an $1.11 EPS. This beat was mainly driven by Nike’s direct sales growing at a faster pace than estimated. Although direct sales were the larger performer of revenue, BMO says that the companies digital sales grew the most at 29% year over year.

BMO says that they are forecasting fiscal 2022 revenue growth to be +MSD, as management noted that there are some severe supply chain impacts which equate to about 10 weeks of lost production in Vietnam.

Below you can see BMO’s updated second quarter estimates.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

This Gold Story Starts With Cash Flow | Gordon Robb – ESGold

Silverco Cusi Mine PEA: Bigger Isn’t Always Better

Fixing Heart Disease Tied to Sudden Death in Young People | David Elsley – Cardiol Therapeutics

Recommended

Total Metals Secures High Grade Critical Minerals Property In Northwestern Ontario

Discovery at Luis Hill Prompts Acceleration of Phase 2 Program for Questcorp

Related News

Organigram: Canaccord Lowers Price Target To $2.50

Yesterday, Organigram Holdings (TSX: OGI) (NASDAQ: OGI) reported their fourth quarter financials. The company announced...

Tuesday, December 1, 2020, 11:17:00 AM

Amazon: BMO Lowers Estimates Due To Expected Headwinds

On October 28th, Amazon.com Inc (NASDAQ: AMZN) reported its 2021 third quarter financial results. The...

Monday, November 1, 2021, 10:14:00 AM

Equinox Gold Sees BMO Lower Price Target To $11.50

At the end of January, Equinox Gold Corp. (TSX: EQX) announced its 2022 production guidance....

Thursday, February 10, 2022, 06:04:00 PM

Osisko Gold Royalties Sees BMO Reiterate $17 Price Target

On July 12, Osisko Gold Royalties (TSX: OR) announced their preliminary second-quarter deliveries, revenues, and...

Thursday, July 14, 2022, 10:56:00 AM

Verano: Canaccord Drops Price Target After Revenue Miss

On November 16th, Verano Holdings (CSE: VRNO) announced its third quarter financial results. The company...

Thursday, November 18, 2021, 11:44:00 AM